Related Experiment Video
Updated: May 21, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV)
Yohan Kim1, Kerrie Vaughan, Jason Greenbaum
1The Immune Epitope Database (IEDB), La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
Insights
Hepatitis C virus (HCV) infection impacts 3% of the global population. This study analyzes HCV epitopes, revealing distinct patterns of T cell and antibody responses and highlighting areas for potential therapeutic development.
Area of Science:
- Immunology
- Virology
- Bioinformatics
Background:
- Hepatitis C virus (HCV) infection affects approximately 3% of the world population, posing a significant global health challenge.
- Over 400 scientific reports contain immunological data on T cell and antibody epitopes from HCV.
- The Immune Epitope Database (IEDB) hosts over 1500 T cell and 1900 antibody epitopes related to HCV.
Purpose of the Study:
- To analyze and visualize HCV-related immune epitope data from diverse scientific reports.
- To identify trends in host and HCV genotype-specific immune responses.
- To pinpoint areas of high immune reactivity and research focus across HCV proteins.
Main Methods:
- Assembled large datasets of HCV epitope data from the IEDB and literature.
- Developed a novel strategy to map epitopes onto reference genomes and visualize response frequencies.
- Analyzed immune reactivity patterns, including correlations with hydrophilicity, hydrophobicity, and sequence variability.
Main Results:
- Identified distinct antibody and T cell (CD4, CD8) epitope targets across HCV proteins.
- Antibody responses correlated with epitope hydrophilicity, while T cell responses correlated with hydrophobicity.
- Frequently recognized epitopes by both T and B cells showed low sequence variability, suggesting potential for vaccine development.
Conclusions:
- The study provides a comprehensive overview of HCV immune epitope landscape, revealing distinct reactivity patterns.
- Highlighted areas of intense research and potential therapeutic targets for HCV infection.
- Emphasized the need for further research into antibody epitopes associated with virus neutralization.
Abstract:
Approximately 3% of the world population is infected by HCV, which represents a major global health challenge. Almost 400 different scientific reports present immunological data related to T cell and antibody epitopes derived from HCV literature. Analysis of all HCV-related epitope hosted in the Immune Epitope Database (IEDB), a repository of freely accessible immune epitope data, revealed more than 1500 and 1900 distinct T cell and antibody epitopes, respectively. The inventory of all data revealed specific trends in terms of the host and the HCV genotypes from which sequences were derived. Upon further analysis we found that this large number of epitopes reflects overlapping structures, and homologous sequences derived from different HCV isolates. To access and visualize this information we developed a novel strategy that assembles large sets of epitope data, maps them onto reference genomes and displays the frequency of positive responses. Compilation of the HCV immune reactivity from hundreds of different studies, revealed a complex and thorough picture of HCV immune epitope data to date. The results pinpoint areas of more intense reactivity or research activities at the level of antibody, CD4 and CD8 responses for each of the individual HCV proteins. In general, the areas targeted by the different effector immune functions were distinct and antibody reactivity was positively correlated with hydrophilicity, while T cell reactivity correlated with hydrophobicity. At the sequence level, epitopes frequently recognized by both T cell and B cell correlated with low variability, and our analysis thus highlighted areas of potential interest for practical applications. The human reactivity was further analyzed to pinpoint differential patterns of reactivity associated with acute versus chronic infection, to reveal the apparent impact of glycosylation on T cell, but not antibody responses, and to highlight a paucity of studies involved antibody epitopes associated with virus neutralization.
More Related Videos
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction